HighPoint Advisor Group LLC Invests $221,000 in Integer Holdings Co. (NYSE:ITGR)

HighPoint Advisor Group LLC purchased a new stake in Integer Holdings Co. (NYSE:ITGR) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,235 shares of the medical equipment provider’s stock, valued at approximately $221,000.

A number of other large investors also recently bought and sold shares of ITGR. Quadrature Capital Ltd acquired a new position in shares of Integer in the fourth quarter worth about $378,000. Congress Asset Management Co. MA increased its position in shares of Integer by 12.5% in the fourth quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock valued at $41,765,000 after buying an additional 46,776 shares in the last quarter. Public Employees Retirement Association of Colorado raised its stake in shares of Integer by 3,260.1% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after buying an additional 276,944 shares during the period. Campbell & CO Investment Adviser LLC lifted its position in shares of Integer by 345.9% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 11,900 shares of the medical equipment provider’s stock valued at $1,179,000 after buying an additional 9,231 shares in the last quarter. Finally, Connable Office Inc. grew its stake in Integer by 22.6% in the 4th quarter. Connable Office Inc. now owns 5,626 shares of the medical equipment provider’s stock valued at $557,000 after acquiring an additional 1,037 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Integer

In other news, EVP John A. Harris sold 1,521 shares of the stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total transaction of $183,189.24. Following the completion of the transaction, the executive vice president now directly owns 4,922 shares in the company, valued at approximately $592,805.68. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Integer news, Director James F. Hinrichs sold 9,603 shares of the business’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $122.44, for a total value of $1,175,791.32. Following the sale, the director now owns 7,424 shares of the company’s stock, valued at $908,994.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP John A. Harris sold 1,521 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total value of $183,189.24. Following the transaction, the executive vice president now owns 4,922 shares of the company’s stock, valued at $592,805.68. The disclosure for this sale can be found here. Insiders have sold 17,936 shares of company stock worth $2,130,937 over the last quarter. 2.00% of the stock is currently owned by company insiders.

Integer Stock Up 0.2 %

NYSE ITGR opened at $116.02 on Friday. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. Integer Holdings Co. has a 52 week low of $69.40 and a 52 week high of $123.99. The business’s fifty day simple moving average is $117.21 and its 200-day simple moving average is $109.47. The firm has a market cap of $3.89 billion, a PE ratio of 40.15, a P/E/G ratio of 1.71 and a beta of 1.16.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.87 EPS. As a group, equities analysts anticipate that Integer Holdings Co. will post 5.27 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. KeyCorp increased their price objective on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. Benchmark restated a “buy” rating and issued a $130.00 target price on shares of Integer in a research report on Friday, May 10th. CL King assumed coverage on Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target for the company. Finally, Citigroup raised their price objective on Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $128.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.